Keyphrases
3,4-methylenedioxymethamphetamine
91%
Ecstasy
75%
Pharmacokinetics
54%
Placebo
50%
Gas Chromatography-mass Spectrometry
45%
Cannabis
41%
Meta-analysis
40%
Hydroxytyrosol
39%
Healthy Volunteers
37%
Subjective Effects
32%
Olive Oil
31%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
30%
Plasma Concentration
30%
Pharmacological Effects
28%
Mephedrone
28%
Alcohol
28%
Human Urine
28%
Systematic Meta-analysis
26%
Ethanol
26%
Cannabis Users
26%
Clinical Trials
25%
Clinical Pharmacology
25%
Oral Fluid
24%
Cytochrome P450 2D6 (CYP2D6)
23%
Oral Administration
23%
Virgin Olive Oil
23%
Flunitrazepam
22%
Cannabis Use
22%
Urine Samples
22%
Amphetamine
22%
Synthetic Cannabinoids
21%
Cocaine
21%
Social Anxiety Disorder
20%
Olive Polyphenols
20%
Down Syndrome
18%
New Psychoactive Substances
18%
Paracetamol
17%
Paroxetine
17%
Phenolic Compounds
17%
Repeated Dose
16%
Cmax
16%
Spain
16%
Pharmacology
15%
Cannabinoids
15%
Metabolism
15%
Cocaine Dependence
15%
Human Plasma
15%
Methadone
14%
Acute Effects
14%
Antidepressants
13%
Pharmacology, Toxicology and Pharmaceutical Science
MDMA
100%
Pharmacokinetics
66%
Placebo
42%
Cannabis
34%
Opiate
30%
Clinical Trial
29%
Subjective Effects
29%
Mephedrone
28%
Disease
26%
Cannabinoid
26%
Normal Human
26%
Ethanol
25%
Flunitrazepam
23%
Biological Marker
22%
Adverse Event
19%
Clinical Pharmacology
18%
Methadone
17%
Prevalence
17%
Paracetamol
17%
CYP2D6
16%
Cathinone
16%
Hydroxytyrosol
15%
Cocaine Dependence
15%
Toxic Injury
15%
Psychostimulant
14%
Observational Study
14%
Antidepressant
14%
Glucuronide
14%
Psychotomimetic
13%
Bioavailability
13%
Tolerability
13%
Diamorphine
13%
Psychotropic Agent
12%
Serotonin
12%
Attention Deficit Disorder
11%
Pharmacodynamics
11%
Virgin Olive Oil
11%
Receptor
10%
Paroxetine
10%
Cytochrome P450
10%
Cohort Study
10%
High Performance Liquid Chromatography
10%
Atomoxetine
10%
Adverse Drug Reaction
10%
Growth Hormone
9%
Drug Dependence
8%
Drug Administration
8%
Analgesic Agent
8%
Infection
8%
Catechol
8%